4,5-二氟-1,2-苯二甲醇 | 854519-97-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4,5-二氟-1,2-苯二甲醇
• 英文名称: (4,5-difluoro-1,2-phenylene)dimethanol
• 英文别名: [4,5-difluoro-2-(hydroxymethyl)phenyl]methanol
• CAS: 854519-97-4
• 化学式: C₈H₈F₂O₂
• mdl: MFCD08695028
• 分子量: 174.147
• InChiKey: ZUGKYQRAGXKKTO-UHFFFAOYSA-N

物化性质

• 沸点：
  288.2±35.0 °C(Predicted)
• 密度：
  1.387±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险性防范说明：
  P261,P264,P271,P280,P302+P352,P304+P340,P305+P351+P338,P312,P362,P403+P233,P501
• 危险性描述：
  H315,H319,H335

反应信息

• 作为反应物：
  描述：

  4,5-二氟-1,2-苯二甲醇 在 氢溴酸 、 四丁基硫酸氢铵 、 potassium carbonate 作用下， 以 水 、 乙腈 为溶剂， 反应 6.0h， 生成 Ethyl 5,6-difluoro-2-isocyano-1,3-dihydroindene-2-carboxylate
  参考文献：
  名称：

  WO2008/151211

  摘要：

  公开号：
• 作为产物：
  描述：

  4,5-二氟邻苯二甲酸 在 lithium aluminium tetrahydride 、 硫酸 作用下， 以 四氢呋喃 为溶剂， 反应 7.0h， 生成 4,5-二氟-1,2-苯二甲醇
  参考文献：
  名称：

  INDANE DERIVATIVES FOR USE IN THE TREATMENT OF BACTERIAL INFECTION

  摘要：

  本发明涉及一种化合物，该化合物属于 Formula (I) 中的茚烷，或其药学上可接受的盐，其中 R1、R2、R3、R4、R5、R6、n 和 p 如本文所定义。这些化合物在抗菌感染的治疗中非常有用，可以作为独立的抗生素使用，也可以与其他抗生素组合使用。

  公开号：

  EP3628666A1

文献信息

• [EN] CHEMICAL COMPOUNDS AS ANTIBIOTICS<br/>[FR] COMPOSÉS CHIMIQUES UTILISÉS COMME ANTIBIOTIQUES
  申请人：ANTABIO SAS

  公开号：WO2018172423A1

  公开（公告）日：2018-09-27

  The invention relates to a compound which is an indane derivative according to Formula (I), or a pharmaceutically acceptable salt thereof, [FORMULA (I)] wherein R1, R2, R3, n, R4, p¸ q, L, ׇ, X and m are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics. The compounds can also be used in vitro, for example in cleaning compositions.

  该发明涉及一种化合物，根据式（I）为茚烷衍生物，或其药学上可接受的盐，[式（I）]其中R1、R2、R3、n、R4、p、q、L、ׇ、X和m如本文所定义。这些化合物在抗菌感染的治疗中非常有用，可以作为独立抗生素使用，也可以与其他抗生素联合使用。这些化合物还可以在体外使用，例如在清洁组合物中。
• Indanyl-piperazine compounds
  申请人：De Nanteuil Guillaume

  公开号：US20060223830A1

  公开（公告）日：2006-10-05

  A compound selected from those of formula (I): wherein: R 3 represents a hydrogen atom, and R 1 and R 2 together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, or R 1 represents a hydrogen atom, and R 2 and R 3 together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, n represents 1 or 2, —X— represents a group selected from —(CH 2 ) m —O-Ak-, —(CH 2 ) m —NR 4 -Ak-, —(CO)—NR 4 -Ak- and —(CH 2 ) m —NR 4 -(CO)—, m represents an integer between 1 and 6 inclusive, Ak represents an optionally substituted alkylene chain, and R 4 represents a hydrogen atom or an alkyl group, Ar represents an aryl or heteroaryl group, its enantiomers, diasteroisomers, and addition salts thereof with a pharmaceutically acceptable acid. Medical products containing the same which are useful in the treatment of conditions requiring a serotonin reuptake inhibitor and/or NK 1 antagonist.

  从公式（I）中选择的化合物：其中：R3代表氢原子，R1和R2与携带它们的碳原子一起形成苯、萘或喹啉环结构，每个环结构可选择地被取代，或R1代表氢原子，R2和R3与携带它们的碳原子一起形成苯、萘或喹啉环结构，每个环结构可选择地被取代，n代表1或2，-X-代表从-(CH2)m-O-Ak-、-( )m-NR4-Ak-、-(CO)-NR4-Ak-和-( )m-NR4-(CO)-中选择的基团，m代表1到6之间的整数，Ak代表可选择地取代的烷基链，R4代表氢原子或烷基基团，Ar代表芳基或杂环芳基基团，它的对映异构体、顺反异构体和与药用酸形成的加合物。含有这些化合物的医药产品在治疗需要血清素再摄取抑制剂和/或NK1拮抗剂的病症中有用。
• IDO/TDO Inhibitor
  申请人：GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION

  公开号：US20200239452A1

  公开（公告）日：2020-07-30

  A compound of formula (I) given below or a pharmaceutically acceptable salt of the compound is useful as an IDO/TDO inhibitor. Thus, the compound of formula (I) or the pharmaceutically acceptable salt of the compound can be used as, for example, a therapeutic agent for a disease or a disorder selected from tumor, infectious disease, neurodegenerative disorder, cataract, organ transplant rejection, autoimmune disease, postoperative cognitive impairment, and disease related to women's reproductive health [in the following formula (I), ring A represents an aromatic ring, an aliphatic ring, a heterocyclic ring, or a condensed ring of two or more rings selected from an aromatic ring, an aliphatic ring and a heterocyclic ring; X, R 1 and R 2 represent a substituent on a ring atom constituting ring A; m represents an integer of 0 to 6; X represents, for example, a halogen atom; and R 1 and R 2 are the same or different and are selected from, for example, the group consisting of groups of formula (a) or formula (b); and in the following formula (a) and formula (b), Y is selected from the group consisting of O, S, and Se, Z is selected from the group consisting of O, S, and Se, n represents an integer of 1 to 8, r represents an integer of 1 to 8, s represents an integer of 1 to 8, R 4 represents, for example, —C(═NH)—HN 2 , and R 6 represents, for example, a substituted or unsubstituted aryl group].

  以下公式（I）给出的化合物或该化合物的药学上可接受的盐可用作IDO/TDO抑制剂。因此，公式（I）的化合物或该化合物的药学上可接受的盐可用作，例如，用于肿瘤、传染病、神经退行性疾病、白内障、器官移植排斥、自身免疫疾病、术后认知障碍以及与女性生殖健康相关的疾病的治疗剂。在以下公式（I）中，环A代表芳香环、脂环、杂环或两个或更多个选自芳香环、脂环和杂环的缩合环的环；X、R1和R2代表构成环A的环原子上的取代基；m代表0到6的整数；X代表例如卤素原子；R1和R2相同或不同，选自例如由公式（a）或公式（b）组成的基团，而在以下公式（a）和公式（b）中，Y选自O、S和Se组成的基团，Z选自O、S和Se组成的基团，n表示1到8的整数，r表示1到8的整数，s表示1到8的整数，R4代表例如—C(═NH)—HN2，R6代表例如取代或未取代的芳基。
• [EN] COMBINATION THERAPY<br/>[FR] POLYTHÉRAPIE
  申请人：ANTABIO SAS

  公开号：WO2021191240A1

  公开（公告）日：2021-09-30

  The invention provides a combinations and pharmaceutical compositions comprising (i) a compound which is an indane according to Formula (I) or a pharmaceutically acceptable salt thereof; and (ii) one or more CFTR modulator; wherein R1, R2, R3, R4, n, Lk, (A), G and m are as defined herein. Also provided are therapeutic uses of such combinations and compositions in the treatment of conditions such as cystic fibrosis.

  该发明提供了一种组合物和含有以下成分的药物组合物：（i）一种符合式（I）中的茚烷化合物或其药用盐；和（ii）一种或多种CFTR调节剂；其中R1、R2、R3、R4、n、Lk、（A）、G和m的定义如本文所述。还提供了这些组合物和组合物在治疗囊性纤维化等疾病条件中的治疗用途。
• Organic semiconducting layers
  申请人：Brown Beverley

  公开号：US20070102696A1

  公开（公告）日：2007-05-10

  An organic semiconducting layer formulation, which comprises: an organic binder which has a permittivity, ∈, at 1,000 Hz of 3.3 or less; and a polyacene compound of Formula: A: wherein: each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and (R 12 , which may be the same or different, independently represents hydrogen; an optionally substituted C 1 -C 40 carbyl or hydrocarbyl group; an optionally substituted C 1 -C 40 alkoxy group; an optionally substituted C 6 -C 40 aryloxy group; an optionally substituted C 7 -C 40 alkylaryloxy group; an optionally substituted C 2 -C 40 alkoxycarbonyl group; an optionally substituted C 7 -C 40 aryloxycarbonyl group; a cyano group (—CN); a carbamoyl group (—C(═O)NH 2 ); a haloformyl group (—C(═O)—X, wherein X represents a halogen atom); a formyl group (—C(═O)—H); an isocyano group; an isocyanate group; a thiocyanate group or a thioisocyanate group; an optionally substituted amino group; a hydroxy group; a nitro group; a CF 3 group; a halo group (CI, Br, F); or an optionally substituted silyl group; and wherein independently each pair of R 2 and R 3 and/or R 8 and R 9 , may be cross-bridged to form a C 4 -C 40 saturated or unsaturated ring, which saturated or unsaturated ring may be intervened by an oxygen atom, a sulphur atom or a group shown by formula —N(R a )— (wherein R a is a hydrogen atom or an optionally substituted hydrocarbon group), or may optionally be substituted; and wherein one or more of the carbon atoms of the polyacene skeleton may optionally be substituted by a heteroatom selected from O N, P, As, O, S, Se and Te; and wherein independently any two or more of the substituents R 1 -R 12 which are located on adjacent ring positions of the polyacene may, together, optionally constitute a further C 4 -C 40 saturated or unsaturated ring optionally interrupted by O, S or —N(R a ) where R a is as defined above) or an aromatic ring system, fused to the polyacene; and wherein n is 0, 1, 2, 3 or 4, also claimed is an electronic device, particularly an organic field effect transistor comprising the organic semiconductor layer formulation.

  一种有机半导体层配方，包括：具有介电常数在1,000 Hz时为3.3或更低的有机粘合剂；以及式子A的聚芳烃化合物： 其中，R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11和（R12，可以相同或不同，独立地代表氢；可选地取代的C1-C40卡烷基或烃基；可选地取代的C1-C40烷氧基；可选地取代的C6-C40芳氧基；可选地取代的C7-C40烷基芳氧基；可选地取代的C2-C40烷氧羰基基团；可选地取代的C7-C40芳氧羰基基团；氰基（—CN）；氨基甲酰基（—C（═O）NH2）；卤甲基基团（—C（═O）—X，其中X代表卤素原子）；甲酰基（—C（═O）—H）；异氰基基团；异氰酸酯基团；硫氰酸基团或硫代异氰酸基团；可选地取代的氨基团；羟基；硝基；CF3基团；卤素基团（CI，Br，F）；或可选地取代的硅基团；其中，独立地，R2和R3和/或R8和R9的任意一对可以通过交叉桥接形成一个饱和或不饱和的C4-C40环，该饱和或不饱和的环可以由氧原子，硫原子或由式子—N（Ra）—（其中Ra是氢原子或可选地取代的碳氢基团）所示的基团介入，或者可以可选地被取代；聚芳烃骨架的一个或多个碳原子可以可选地被从O、N、P、As、O、S、Se和Te中选择的杂原子所取代；独立地，位于聚芳烃上相邻环位置的两个或多个取代基R1-R12中的任意两个或多个，可以一起可选地构成进一步的C4-C40饱和或不饱和环，该环可被O、S或—N（Ra）（其中Ra如上定义）或融合到聚芳烃中的芳香环系统中打断；n为0、1、2、3或4。此外，还声明了一种电子器件，特别是包括有机半导体层配方的有机场效应晶体管。